Cargando…

Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients: Prolonged RNA Detection in Whole Blood

BACKGROUND: Clinical, virologic, and immunologic characteristics of Zika virus (ZIKV) infections in US patients are poorly defined. METHODS: US subjects with suspected ZIKV infection were enrolled. Clinical data and specimens were prospectively collected for ZIKV RNA detection and serologic and cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Sahly, Hana M, Gorchakov, Rodion, Lai, Lilin, Natrajan, Muktha S, Patel, Shital M, Atmar, Robert L, Keitel, Wendy A, Hoft, Daniel F, Barrett, Jill, Bailey, Jason, Edupuganti, Srilatha, Raabe, Vanessa, Wu, Henry M, Fairley, Jessica, Rouphael, Nadine, Murray, Kristy O, Mulligan, Mark J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343961/ https://www.ncbi.nlm.nih.gov/pubmed/30697574 http://dx.doi.org/10.1093/ofid/ofy352

Ejemplares similares

2492. Clinical, Virologic, and Immunologic Characteristics of Zika Virus Infection in a Cohort of US Patients
por: Sahly, Hana M El, et al.
Publicado: (2018)

Biphasic Zika Illness With Rash and Joint Pain
por: Edupuganti, Srilatha, et al.
Publicado: (2017)

Pericarditis Associated With Acute Zika Virus Infection in a Returning Traveler
por: Waggoner, Jesse J., et al.
Publicado: (2017)

Prolonged Detection of Zika Virus in Vaginal Secretions and Whole Blood
por: Murray, Kristy O., et al.
Publicado: (2017)

Innate, T-, and B-Cell Responses in Acute Human Zika Patients
por: Lai, Lilin, et al.
Publicado: (2018)

Optimizing PCR Detection of Zika Virus from Various Body Fluids
por: Gorchakov, Rodion, et al.
Publicado: (2019)

Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus
por: Sheikh, Daanish, et al.
Publicado: (2023)

2739. Comparison of Hemagglutination Antibody Inhibition (HAI) Titers Following Influenza Vaccination by Birth Cohort and Repeated Influenza Vaccination History
por: Sherman, Amy C, et al.
Publicado: (2019)

846. Postnatally Acquired Zika Virus (ZIKV) Infection in Infants and Young Children in Guatemala: Serologic and Neurodevelopmental (ND) Evaluation
por: Munoz, Flor M, et al.
Publicado: (2019)

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
por: Frey, Sharon E., et al.
Publicado: (2015)

The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination
por: Sherman, Amy C., et al.
Publicado: (2020)

Pre-Existing Dengue Immunity Drives a DENV-Biased Plasmablast Response in ZIKV-Infected Patient
por: Bhaumik, Siddhartha K., et al.
Publicado: (2018)

Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus Inoculum
por: Ibaraki, Makoto, et al.
Publicado: (2023)

Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection
por: Acosta, Camilo J, et al.
Publicado: (2022)

Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine
por: Lai, Lilin, et al.
Publicado: (2020)

2801. Post-Natal Zika Virus Infection and Impact on Neurodevelopment Among a Cohort of Children in Rural Guatemala
por: Olson, Daniel, et al.
Publicado: (2019)

Identification of immunodominant T cell epitopes induced by natural Zika virus infection
por: Eickhoff, Christopher S., et al.
Publicado: (2023)

Occupational Exposure to the Ugandan Research Strain (MR766) of Zika Virus
por: Lichtenberger, Paola N, et al.
Publicado: (2019)

Timing of gestational exposure to Zika virus is associated with postnatal growth restriction in a murine model
por: Valentine, Gregory C., et al.
Publicado: (2018)

Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
por: Smith, Teresa C., et al.
Publicado: (2023)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised)
por: Keitel, Wendy A, et al.
Publicado: (2013)

Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center
por: Yoke, Leah H, et al.
Publicado: (2021)

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
por: Fintzi, Jonathan, et al.
Publicado: (2022)

Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections
por: Wang, Grace, et al.
Publicado: (2022)

Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults
por: Simons, Lacy M, et al.
Publicado: (2022)

Virological and Serological Assessment of US Army Trainees Isolated for Coronavirus Disease 2019
por: Hakre, Shilpa, et al.
Publicado: (2022)

Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
por: Chang, Yie-Hwa, et al.
Publicado: (2020)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus
por: Weijsenfeld, Annouschka M, et al.
Publicado: (2022)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks
por: Rolle, Charlotte-Paige, et al.
Publicado: (2023)

Spatial diffusion of Zika fever epidemics in the Municipality of Salvador-Bahia, Brazil, in 2015-2016: does Zika fever have the same spread pattern as Dengue and Chikungunya fever epidemics?
por: Santana, Laís Santos, et al.
Publicado: (2020)

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial
por: Mulligan, Mark J., et al.
Publicado: (2014)

Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses
por: Natrajan, Muktha S., et al.
Publicado: (2019)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
por: Young, Jim, et al.
Publicado: (2017)

Unsatisfactory long-term virological suppression in human immunodeficiency virus-infected children in the Amazonas State, Brazil
por: Pacheco, Ana Luisa Opromolla, et al.
Publicado: (2020)

Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents
por: Mills, Anthony M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r50h104lkbcfq5i0vgcgriau8n